News | March 31, 2020
Columbia University Medical Center. In an effort to provide dermatology care to patients at home during COVID-19. Columbia University Medical Center had launched a robust Telehealth system so patients can see a dermatologist from any...
News | March 12, 2020
Psoriasis patients diagnosed with COVID-19 (coronavirus disease) should immediately discontinue or postpone immunosuppressant medications, guidance from the International Psoriasis Council (IPC) states. The group cites current guidance from...
A Sun Pharma survey finds up to 44% of moderate-to-severe psoriasis patients often or sometimes feel humiliated by the appearance of plaques. Patients report effects on intimacy and relationships. Ortho Dermatologics adds telemedicine and new products to Dermatology.com. South Beach Symposium faculty shed light on therapeutic developments and the state of dermatology.
News | February 13, 2020
The impact of moderate-to-severe plaque psoriasis on social and personal interactions can be extensive, results of a new survey from Sun Pharma confirm. In fact, 44 percent of respondents said that they often or sometimes feel humiliated by...
2019 was bookended by the release of new treatment guidelines for pediatric skin disorders. Sheila Fallon Friedlander, MD, gives an overview of these developments and other hot topics in pediatric dermatology.
Dermavant Completes Patient Enrollment for Two Phase 3 Clinical Trials of Tapinarof for Psoriasis
Industry Responds to COVID-19: Columbia University Medical Center, RealSelf, Thrive Causemetics
International Psoriasis Council Offers Guidance on Managing COVID-19 in People with Psoriasis
DermWireTV: Sun's PsO Impact Survey, Dermatology.com Expansion, More
Resident of Distinction Award Celebrates 10th Anniversary at 2020 Caribbean Dermatology Symposium